OMDA

11.8605.12%
WS

Wei-Li Shao

President

Mr. Wei-Li Shao is President of Omada Health, Inc. from December 2021 and served as its Chief Commercial Officer from May 2019 to December 2021. Prior to joining Omada Health, Inc., Mr. Shao held various roles at Eli Lilly and Company from 2001 to February 2019, including Vice President of Lilly China Diabetes, General Manager of Lilly Taiwan, Lilly New Zealand and most recently as Vice President of the U.S. Neuroscience Business Unit. Mr. Shao holds a B.S. in Biochemistry from the University of Wisconsin-Madison and an M.B.A. from Indiana University’s Kelley School of Business.

Positions